Physician profile
Michael E Seiff
NPI 1992762215
$334,912.26
in general payments reported to CMS, 2019-2025
25 companies · $41K in 2025
The $41K reported for 2025 was more than what 94% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $25K · 2020: $30K · 2021: $46K · 2022: $52K · 2023: $62K · 2024: $79K · 2025: $41K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $180K · Food and Beverage: $1,732 · Travel and Lodging: $583.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $179,757.35 |
| Food and Beverage | $1,731.62 |
| Travel and Lodging | $583.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kls-Martin L.P. | $325,696.53 | 2019-2025 | Neuro |
| Cerapedics INC. | $6,529.10 | 2021 | |
| Medtronic, INC. | $550.50 | 2022-2025 | Stealthstation S8 Platform, Osteocool Rf Ablation System, Strata |
| Providence Medical Technology, INC. | $526.01 | 2019-2025 | |
| Sanara Medtech INC. | $284.17 | 2024 | Celleraterx |
| Nevro Corp. | $197.18 | 2020-2022 | |
| Livanova USA, INC. | $193.22 | 2021-2024 | Vns Therapy Sentiva Model 1000 Generator |
| Intrinsic Therapeutics | $175.00 | 2025 | Barricaid Acd (Annular Closure Device) |
| Si-Bone, INC. | $163.53 | 2019-2024 | |
| Elutia, INC. | $90.11 | 2022 | |
| Gt Medical Technologies, INC | $85.34 | 2025 | Gammatile |
| Camber Spine Technologies LLC | $59.68 | 2019 | |
| Nuvasive, INC. | $47.61 | 2019 | |
| Ge Healthcare | $40.82 | 2025 | |
| Microtransponder, INC. | $39.00 | 2023 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Healthmyne, INC. | $32.25 | 2019 | |
| Bioventus LLC | $31.80 | 2024 | Bonescalpel & Sonicone (O.R.) |
| Medtronic USA, INC. | $31.76 | 2019 | |
| Integra Lifesciences Corporation | $26.12 | 2019 | |
| Glaxosmithkline, LLC. | $23.14 | 2021 | |
| Ceribell, INC. | $22.36 | 2021 | |
| Depuy Synthes Sales INC. | $19.34 | 2025 | Teligen |
| Zimmer Biomet Holdings, INC. | $18.63 | 2021 | |
| Arbor Pharmaceuticals, INC. | $17.14 | 2019 | |
| Portola Pharmaceuticals, LLC | $11.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Seiff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.